Skip to main content
Signal8

Voermann Karsten

SEC insider (Form 3/4/5 filer). CIK 0001822140. Chief Financial Officer at GoodRx Holdings, Inc. (GDRX). 6 reported Form 4/5 transactions since Sep 2024; latest on Jan 8, 2025. Located in SANTA MONICA, CA.

Companies Voermann Karsten has filed insider reports for

  • GoodRx Holdings, Inc. (GDRX): Officer, Chief Financial Officer
Voermann Karsten profile photo

Voermann Karsten

CIK: 0001822140

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)3 (50.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

GoodRx Holdings, Inc. logo
GDRX

GoodRx Holdings, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • GoodRx Holdings, Inc. logo
    GDRX

    GoodRx Holdings, Inc.

    Jan 8, 2025
    Exercise
    Direct
    89.3K shares-
  • GoodRx Holdings, Inc. logo
    GDRX

    GoodRx Holdings, Inc.

    Jan 8, 2025
    Tax Payment
    Direct
    29K shares at avg. $4.41$128K
  • GoodRx Holdings, Inc. logo
    GDRX

    GoodRx Holdings, Inc.

    Dec 8, 2024
    Exercise
    Direct
    54.1K shares-
  • GoodRx Holdings, Inc. logo
    GDRX

    GoodRx Holdings, Inc.

    Dec 8, 2024
    Tax Payment
    Direct
    24.7K shares at avg. $4.91$121K
  • GoodRx Holdings, Inc. logo
    GDRX

    GoodRx Holdings, Inc.

    Sep 8, 2024
    Exercise
    Direct
    54.1K shares-
  • GoodRx Holdings, Inc. logo
    GDRX

    GoodRx Holdings, Inc.

    Sep 8, 2024
    Tax Payment
    Direct
    24.7K shares at avg. $7.71$190K

1-6 of 6